Mumbai, December 24, 2025: Nanavati Max Super Speciality Hospital proudly announced that Dr. Kaustav Talapatra, Senior Director, Radiation Oncology, has been nominated as the International Ambassador for the American Society for Radiation Oncology (ASTRO). Dr. Talapatra is among the first ambassadors to be chosen from India, marking a significant milestone in India’s growing leadership in advanced, evidence-based cancer care.
The nomination establishes a strategic bridge between ASTRO and the Association of Radiation Oncologists of India (AROI). In his new role, Dr. Talapatra, will lead efforts to expand joint academic initiatives, foster international exchange and fellowship programmes, and create structured learning pathways for young radiation oncologists across the country.
Commenting on the recognition, Dr. Kaustav Talapatra, Senior Director, Radiation Oncology, said, “This honour is both humbling and deeply motivating. As ASTRO’s International Ambassador from India, my focus will be on building sustainable academic bridges and ensuring that global advances in radiation oncology translate into tangible benefits for our patients at home and our young oncologists.”
Dr. Talapatra has been a pivotal figure in bringing global oncology standards to India over the past decade. He was involved in launching ‘Best of ASTRO’ in India—a premier academic resource that provides Indian practitioners access to the top research presented at the annual ASTRO conference in the United States.
In a special message, Dr. Vivek Kavadi, CEO of ASTRO, noted that the ambassador programme marks the beginning of a significant new chapter of cooperation between ASTRO and AROI, with the potential to profoundly enhance oncology education and clinical practice in India.
Resonating this sentiment, Dr. S. N. Senapati, President of AROI, said, “This partnership will empower radiation oncologists across both organisations and ultimately translate into more equitable care for cancer patients. The ASTRO ambassador appointment and AROI’s engagement will foster innovation and help shape the future of radiation oncology.”
Further, remarking on the achievement, Dr. Vivek Talaulikar, Head – Western Region, Max Healthcare, said, “Dr. Talapatra’s nomination is a landmark moment for Max Healthcare and for the new generation of oncologists. It affirms our belief that Indian clinicians can shape global standards of care and inspires younger doctors to pursue excellence, innovation, and compassionate cancer treatment for the masses.”
In addition to its leadership in radiation oncology, Nanavati Max Hospital’s Cancer Institute provides a comprehensive range of advanced oncology services, including surgical oncology, medical oncology, robotic-assisted surgeries, and personalized targeted therapies, maintaining its position as a specialized centre for holistic cancer management.
